Bortezomib, lenalidomide, and dexamethasone as induction therapy prior to autologous transplant in multiple myelomaLaura Rosiñol, Joan Bladé, Albert Oriol et al.|Blood|2019Cited by 218
Lenalidomide and dexamethasone maintenance with or without ixazomib, tailored by residual disease status in myelomaLaura Rosiñol, Joan Bladé, Albert Oriol et al.|Blood|2023Cited by 62
Optical Genome Mapping ( <scp>OGM</scp> ): Validation and Clinical Utility in the Cytogenetic Diagnosis of Multiple MyelomaAdela Cisneros, Isabel Granada, Neus Ruiz‐Xivillé et al.|American Journal of Hematology|2025Cited by 1